AEGiS-04CROI: CD40 ligand (CD40L) stimulates human macrophages to produce large amounts of HIV-suppressive beta-chemokines.

4th Conference on Retroviruses and Opportunistic Infections


Washington, DC - January 22-26, 1997


Print this Article


CD40 ligand (CD40L) stimulates human macrophages to produce large amounts of HIV-suppressive beta-chemokines.

Conf Retroviruses Opportunistic Infect 1997 Jan 22-26; 4th:69 (abstract no. 23)

Kornbluth RS, Kee K, Richman DD; Univ. of California, San Diego, CA.


CD40L is rapidly expressed (5 min-2 h) on the membranes of certain CD4+ and CD8+ T cells upon activation of the T cell receptor. Macrophages express CD40 and are activated upon contact with a CD40L-expressing cell. To study this further, 293 cells stably transfected with a human CD40L construct or the control empty vector were prepared, added to monocyte-derived macrophages cultures, and supernatants were collected. By ELISA, CD40L-293 cells (but not control 293 cells) induced 2-6 ng/ml of MIP-1alpha, 4-10 ng/ml of MIP-1 beta, and 0.3-0.6 ng/ml of RANTES in 24 h. Chemokine release commenced 3 h after CD40L stimulation. On a per cell per day basis, the amounts of MIP-1 produced exceed that of any T cell yet described. These data support the reported finding that macrophages and not CD8+ T cells are the principal beta-chemokine-producing cells in lymph nodes from HIV-infected individuals (N. Tedla et al., Amer J Pathol 1996;148:1367-73). Significantly, supernatants from the CD40L-stimulated macrophages completely protected purified CD4+ T cells from infection by NSI HIV-1. Dendritic cells have also been reported to produce MIP-1alpha following CD40L stimulation. These data suggest that CD40L-expressing T cells directed against HIV antigens may play a protective role by rapidly stimulating macrophages to produce HIV-suppressive beta-chemokines.
Keywords: AEGIS, Chemokines, CC, HIV, CD40 Ligand, Macrophages, Macrophage Inflammatory Protein-1, HIV-1, RANTES, HIV Infections, Chemokines, Antigens, CD4, Monocytes, T-Lymphocytes, HIV Long Terminal Repeat, Anti-HIV Agents, Antigens, CD8, Human, genetics, AIDS

970122
23

Copyright © 1980, 1997 - Foundation for Retrovirology and Human Health. Reproduction of this abstract (other than one copy for personal reference) must be cleared through the Foundation for Retrovirology and Human Health. Licensed through AIDSLINE, National Library of Medicine.